Clinical Recommendations

HIVAging leaf The American Academy of HIV Medicine (AAHIVM), the American Geriatrics Society (AGS) and the AIDS Community Research Initiative of America (ACRIA) released the first clinical treatment strategies for managing older HIV patients: The HIV and Aging Consensus Project: Recommended Treatment Strategies for Clinicians Managing Older Patients with HIV in the fall of 2011.

If there is one constant in the field of HIV medicine, it is that of constant change. The science of HIV is an ever changing landscape of new research findings, new medications with new targets and also new side effects. In addition to new populations affected by the epidemic, as the elderly, there is the ever demanding goal of seeking an actual cure for HIV disease.

The authors of the HIV & Aging Recommendations were acutely aware of this fact. In the brief time from the publishing of the document in the fall of 2011 until now, there are many additions, updating of information and re-writes to be completed to keep the document vibrant and relevant.

In anticipation of this reality both the planning committee and expert panel suggested that to keep the recommendations a “living document” that a HIV & Aging Blog be established where a healthy, vibrant dialogue among practitioners, and others could be held. Suggestions for changes to the document would come from those practitioners currently treating elderly HIV patients.

The Expert Panel members and other participants in the HIV & Aging Consensus Project also invite you to join in on this interactive HIV-Age blog become actively involved in advancing the knowledge and communication in this area of medical uncertainty.

This report is part of the Academy’s HIV and Aging Consensus Project, developed to assess how the presence of both HIV and common age-associated diseases, alter the optimal treatment of HIV as well as other co-morbidities. The purpose of this report is to provide best practice guidance for HIV practitioners and other health care providers who treat, diagnose and refer older patients with HIV disease.

Click below to open the entire document. Table of contents are on page 3 and are clickable in the document. If you’d like to access older versions of the chapters, please see our archive page.

The HIV and Aging Consensus Project

Click below to open a specific chapter.

3. UPDATED: Assessing Frailty and Functional Capacity

5. UPDATED: Multi-Morbidity

7. UPDATED: Detection and Screening for HIV in Older Adults (8/22/17)

8. UPDATED: When to Initiate Antiretroviral Therapy in HIV and Aging (6/5/17)

9. UPDATED: Immunizations in HIV and Aging (5/18/17)

10. UPDATED: Smoking in HIV and Aging (6/12/17)

11. UPDATED: Cardiovascular Disease Screening and Prevention in HIV

12. UPDATED: Diabetes Mellitus in HIV and Aging (3/31/17)

13. UPDATED: Drug-drug Interactions and Polypharmacy in HIV and Aging (10/16/17)

14. UPDATED: Cancer in HIV and Aging (8/17/17)

15. UPDATED: Viral Hepatitis Screening in HIV and Aging (10/23/17)

16. UPDATED: Chronic Obstructive Pulmonary Disease in HIV and Aging (8/24/17)

17. UPDATED: Sexual Health in HIV and Aging (10/16/17)

18. UPDATED: Osteoporosis in HIV and Aging

19. UPDATED: The Kidney in HIV and Aging

20. UPDATED: Hypertension in HIV and Aging (8/30/17)

21. UPDATED: Older Age and HIV-Associated Neurocognitive Disorder (HAND) (10/17/17)

22. UPDATED: Depression in HIV and Aging

23. UPDATED: Anxiety Disorders in HIV and Aging

24. UPDATED: Substance Use Disorders

25. UPDATED: HIV-1 Associated Peripheral Neuropathologies in HIV and Aging

26. UPDATED: Advance Care Planning in HIV and Aging (5/18/17)

28. UPDATED: PrEP and the Older Adult with HIV

29. UPDATED: Nutrition in HIV and Aging

Recommended Treatment
Strategies for Clinicians Managing Older Patients with HIV

  • CME/CE credit available October 17, 2016 – November 30, 2017 
  • Estimated time to complete all chapters: 12.25 hours

Target Audience

This activity is intended for physicians and pharmacists and other healthcare providers who treat, diagnose and refer older patients with HIV disease.

Physician Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and American Academy of HIV Medicine. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates these enduring materials for a maximum of 12.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Postgraduate Institute for Medicine designates these continuing education activities for 12.25 contact hour(s) (1.225 CEUs) of the Accreditation Council for Pharmacy Education.

Method of Participation and Request for Credit

There are no fees for participating and receiving CME/CE credit for this activity. During the period October 17, 2016 through November 30, 2017, participants must read the learning objectives and faculty disclosures and study the educational activity.

If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 11671. Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately.

For Pharmacists: Upon successfully completing the post-test with a score of 70% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service.